Sponsor Content
What does this mean?

State Health Agencies Rely on Abbott BinaxNOW COVID-19 At-Home Antigen Test Kits

As more people get vaccinated and states begin to roll back some of the restrictions put in place due to the COVID-19 pandemic — schools, agencies and workplaces are working on a plan on how to safely return to normal.

iPromo_Home Vaccine Kit_header
As more people get vaccinated and states begin to roll back some of the restrictions put in place due to the COVID-19 pandemic — schools, agencies and workplaces are working on a plan on how to safely return to normal. For example, Colorado is distributing 2 million free rapid BinaxNOW tests directly to the homes of employees, and the Ohio Department of Health has secured the purchase of at least 2 million tests that can be self-administered outside of a clinical setting.

Fifty-seven percent of Americans believe that it will still be at least another year before our society looks like it did pre-pandemic1, and frictionless COVID-19 testing efforts are now even more important, as they help our communities build on the positive momentum we’ve seen in recent weeks. The majority of employees worry that they could be exposed to COVID-19 at their place of work, but only 71 percent say they have confidence in their employer’s ability to bring them back to work safely2. How can an employer confidently promise their employees that they are coming back to a safe environment? Ongoing testing.

Frictionless Testing Is Key

The challenge with testing, however, is that standard tests can be inconvenient to get or take several days to produce results. As more people leave behind the strict quarantine mindset, their tolerance for either visiting their health-care provider or waiting to see the test results before heading into work or communities may begin to dwindle.

By far the most widely available option is the Abbott BinaxNOW™ COVID-19 Ag Card Home Kit — an antigen test that detects proteins from the COVID-19 virus in nasal swabs, and can be taken at home without an in-person visit to a health-care provider.3 This test has been granted Emergency Use Authorization (EUA) by the FDA and recently received over $260 million in funding from various branches of the federal government to administer COVID-19 tests at a variety of locations, including schools and nursing homes.4 At just $25 each, iPromo now offers a mass solution for companies aiming to move back to normal, safely.

Trusted and Verified Test Results

This particular test can provide results within 15 minutes, without the sample needing to be sent away for testing, and a test sensitivity of 97.1 percent, which is a test's ability to designate an individual as positive — allowing users to know fairly conclusively if they have COVID-19. Each test is approximately the size of a credit card and is administered under the guidance of an eMed™ Certified Guide to ensure the tests are done correctly, and once the test is completed a digital pass is issued to the user. These visits are completed virtually in real time, so there’s no lag time in setting up an appointment; and once you have your results, Abbott stores them in their NAVICA app, making the results easily accessible for immediate reference.

“As we reopen as a country, the BinaxNOW tests ensure you’re doing everything you can to keep those around you safe and healthy,” shares Leo Friedman, CEO and founder of iPromo, a leading provider of promotional products and personal protective equipment. “Whether you’re looking to start in-office screening, gathering for an off-site meeting or even reopening a library, the Abbott test is the golden standard for timely COVID detection.”

About iPromo

iPromo, established 1999, is a leading supplier of personal protective equipment and promotional products, leveraging trusted manufacturers and overseas sourcing relationships developed over more than two decades in business. For more information, visit



Media Contact:
Brandon Kazimer
Jill Schmidt PR

1 https://www.pewresearch.org/fact-tank/2021/03/11/a-majority-of-americans-expect-it-will-be-at-least-a-year-before-life-returns-to-the-way-it-was-before-covid-19/
2 https://www.ehstoday.com/covid19/article/21130371/50-of-us-employees-worry-about-workplace-exposure-to-covid19
3 https://abbott.mediaroom.com/2021-01-12-Abbott-Announces-Fulfillment-of-Federal-Government-Purchase-of-150-Million-BinaxNOW-TM-COVID-19-Rapid-Tests-and-Is-Now-Ready-to-Support-Commercial-Distribution
4 https://www.medtechdive.com/news/abbott-awarded-255m-federal-contract-for-rapid-covid-19-antigen-tests/596948/